Related Documents
-
Notice: Human drugs:
New drug applications— INSPRA
195 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— APTIVUS
165 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— SURPASS
48 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— PREVICOX
22 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— TARCEVA
38 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— CLINACOX
39 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— ALAMAST
42 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— Premarket approval applications, list; safety and effectiveness summaries availability
165 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— MYCAMINE
74 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— PRIALT
19 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— MYCAMINE
85 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— INCRELEX
42 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— IPLEX
15 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— CLOLAR
22 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— OVIDREL
49 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— LUVERIS
30 reads -
Notice: Human drugs: BONIVA
64 reads -
Notice: Committees; establishment, renewal, termination, etc.: BYETTA
63 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— FUZEON
82 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— PLENAXIS
17 reads





Related Documents
Flag this document
2 Pages